+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Differential crosstalk between the AMPK and PI3K/Akt pathways in breast cancer cells of differing genotypes: Leptin inhibits the effectiveness of AMPK activation

Differential crosstalk between the AMPK and PI3K/Akt pathways in breast cancer cells of differing genotypes: Leptin inhibits the effectiveness of AMPK activation

Oncology Reports 34(4): 1675-1680

AMP-activated protein kinase (AMPK), a sensor of cellular energy, is widely reported as a potential therapeutic target in treatment of breast and other cancers. The activated enzyme has been shown to be a promising anti-proliferative agent in breast cancer cell lines. However, little data exist on crosstalk between AMPK and the cellular survival axis of PI3K/Akt/mTOR pathway and the impact of microenvironment on cellular responses to AMPK activation. We present results which show differential crosstalk between AMPK and Akt, dependent on the cellular genetics of each breast cancer cell type. We also show that leptin blocks activation of AMPK and partially or completely attenuates the anti-proliferative effect of AMPK activation depending on the cell type. This suggests that leptin within the local environment might impose limitations on therapeutic usage of AMPK activators in cancer, thereby attenuating their effective use in many obese subjects.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 057622123

Download citation: RISBibTeXText

PMID: 26260992

DOI: 10.3892/or.2015.4198

Related references

Demethoxycurcumin inhibits energy metabolic and oncogenic signaling pathways through AMPK activation in triple-negative breast cancer cells. Journal of Agricultural and Food Chemistry 61(26): 6366-6375, 2013

PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation. Investigational new Drugs 36(5): 763-772, 2018

Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells. Oncology Reports 27(5): 1488-1496, 2012

Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways. Metallomics 9(5): 535-545, 2017

AICAR, an AMPK activator, sensitizes TRAIL-mediated apoptosis through p38 MAPK-dependent and AMPK-independent signaling pathways in human bladder cancer T24 cells. European Journal of Cancer 61: S57-S58, 2016

Metformin inhibits β-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells. International Journal of Biochemistry and Cell Biology 112: 88-94, 2019

Age-related changes in AMPK activation: Role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways. Ageing Research Reviews 28: 15-26, 2016

IL-12 induces autophagy in human breast cancer cells through AMPK and the PI3K/Akt pathway. Molecular Medicine Reports 16(4): 4113-4118, 2017

2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways. International Journal of Oncology 37(4): 1023-1030, 2010

Capsaicin induces apoptosis in human osteosarcoma cells through AMPK-dependent and AMPK-independent signaling pathways. Molecular and Cellular Biochemistry 384(1-2): 229-237, 2013

Central leptin action improves skeletal muscle AKT, AMPK, and PGC1 alpha activation by hypothalamic PI3K-dependent mechanism. Molecular and Cellular Endocrinology 314(1): 62-69, 2010

Anticancer Effects of a Korean Herbal Medicine Formula (H9) via AMPK and HER2-PI3K/Akt Signaling in Breast Cancer Cells. PhytoTherapy Research 31(11): 1765-1775, 2017

Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways. Experimental Cell Research 339(1): 67-80, 2015

Antidiabetic Effect of Tibetan Medicine Tang-Kang-Fu-San in db/db Mice via Activation of PI3K/Akt and AMPK Pathways. Frontiers in Pharmacology 8: 535, 2017

Differential regulation of AMPK activation in leptin- and creatine-deficient mice. Faseb Journal 27(10): 4147-4156, 2013